Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney

od Heerspink, Hiddo J L
Izdano u Nephrol Dial Transplant (2019)

Trial Design Innovations to Accelerate Therapeutic Advances in Chronic Kidney Disease: Moving from Single Trials to an Ongoing Platform

od Heerspink, Hiddo J.L., Perkovic, Vlado
Izdano u Clin J Am Soc Nephrol (2018)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease

od Heerspink, Hiddo J. L., De Zeeuw, Dick
Izdano u Diabetologia (2016)

Treating diabetic complications; from large randomized clinical trials to precision medicine

od Heerspink, Hiddo J. L., de Zeeuw, Dick
Izdano u Diabetes Obes Metab (2018)

Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy

od de Zeeuw, Dick, Heerspink, Hiddo J L
Izdano u Nephrol Dial Transplant (2020)

New clinical trial designs for establishing drug efficacy and safety in a precision medicine era

od Heerspink, Hiddo J. L., List, James, Perkovic, Vlado
Izdano u Diabetes Obes Metab (2018)

Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease

od Heerspink, Hiddo J L, Fouque, Denis, Wanner, Christoph
Izdano u Nephrol Dial Transplant (2020)

Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease

od Pena, Michelle J., Mischak, Harald, Heerspink, Hiddo J. L.
Izdano u Diabetologia (2016)

ACCORDION: Ensuring That We Hear the Music Clearly

od Wong, Muh Geot, Heerspink, Hiddo J.L., Perkovic, Vlado
Izdano u Clin J Am Soc Nephrol (2018)

Exposure–response relationships of dapagliflozin on cardiorenal risk markers and adverse events: A pooled analysis of 13 phase II/III trials

od Koomen, Jeroen V., Stevens, Jasper, Heerspink, Hiddo J.L.
Izdano u Br J Clin Pharmacol (2020)

Precision medicine approaches for diabetic kidney disease: opportunities and challenges

od Tye, Sok Cin, Denig, Petra, Heerspink, Hiddo J L
Izdano u Nephrol Dial Transplant (2021)

New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors

od Dekkers, Claire C. J., Gansevoort, Ron T., Heerspink, Hiddo J. L.
Izdano u Curr Diab Rep (2018)

Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?

od Perco, Paul, Pena, Michelle, Heerspink, Hiddo J.L., Mayer, Gert
Izdano u Kidney Int Rep (2018)

Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus

od Vinke, Joanna Sophia J., Heerspink, Hiddo J.L., de Borst, Martin H.
Izdano u Curr Opin Nephrol Hypertens (2019)

No significant association of type 2 diabetes‐related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives

od Martono, Doti P., Heerspink, Hiddo J.L., Hak, Eelko, Denig, Petra, Wilffert, Bob
Izdano u Diabetes Obes Metab (2019)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies

od Olde Engberink, Rik H. G., Heerspink, Hiddo J. L., de Zeeuw, Dick, Vogt, Liffert
Izdano u Br J Clin Pharmacol (2016)

Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects

od Heerspink, Hiddo J. L., Desai, Mehul, Jardine, Meg, Balis, Dainius, Meininger, Gary, Perkovic, Vlado
Izdano u J Am Soc Nephrol (2017)

Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?

od Weldegiorgis, Misghina, de Zeeuw, Dick, Dwyer, Jamie P., Mol, Peter, Heerspink, Hiddo J.L.
Izdano u Clin J Am Soc Nephrol (2017)

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations

od Mol, Peter G. M., Thompson, Aliza, Heerspink, Hiddo J. L., Leufkens, Hubert G. M.
Izdano u Diabetes Obes Metab (2018)

Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin

od Kroonen, Marjolein Y. A. M., Stevens, Jasper, de Zeeuw, Dick, Heerspink, Hiddo J. L.
Izdano u Diabetes Obes Metab (2019)